Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Learn Mem ; 160: 91-97, 2019 04.
Article in English | MEDLINE | ID: mdl-29614375

ABSTRACT

Sleep deprivation is known to affect memory formation, but how it interacts with different memory systems is not completely understood. Adenosine, a homeostatic regulator of sleep that has an increased extracellular concentration during sleep deprivation, is one of the neuromodulators that may be involved in this interaction. The A1 adenosine receptor is involved in both sleep regulation and memory formation. Among other pathways, the A1 receptor decreases cAMP levels in the cytosol and thus also regulates protein kinase A (PKA) and exchange protein activated by cAMP (EPAC) activity. To verify the role of the A1 receptor in the memory impairment caused by sleep deprivation, we tested the effect of 96 h of sleep deprivation (SD) and the administration of DPCPX, an A1 receptor antagonist on male Wistar rats prior to the training sessions for two memory tasks that relies on the hippocampal function: the multiple trial inhibitory avoidance (MTIA) task, which also requires the striatum, and the contextual fear conditioning (CFC) task, which does not. We also evaluated the effect of SD, DPCPX and the MTIA training session on the protein expression levels of the A1 receptor, PKA phosphorylation and EPAC activity in both the hippocampus and the striatum. Sleep deprivation impaired the performance in the test sessions of both tasks; DPCPX was able to prevent the impairment in the MTIA test but not in the CFC test. SD increased A1 receptor protein expression levels in the striatum but not in the hippocampus and also decreased PKA phosphorylation in both structures; DPCPX prevented this decrease in the striatum, but not in the hippocampus. Finally, SD had no effect on EPAC activity in either of the structures. These results indicate that the A1 adenosine receptors play a role in the memory impairment caused by sleep deprivation in tasks that involve the striatum through modulation of the cAMP/PKA pathway.


Subject(s)
Adenosine/metabolism , Avoidance Learning/physiology , Conditioning, Classical/physiology , Cyclic AMP-Dependent Protein Kinases/metabolism , Hippocampus , Memory Disorders , Receptor, Adenosine A1/metabolism , Sleep Deprivation , Adenosine A1 Receptor Antagonists/pharmacology , Animals , Avoidance Learning/drug effects , Behavior, Animal/drug effects , Behavior, Animal/physiology , Conditioning, Classical/drug effects , Down-Regulation , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/physiopathology , Male , Memory Disorders/metabolism , Memory Disorders/physiopathology , Rats , Rats, Wistar , Receptor, Adenosine A1/drug effects , Signal Transduction/drug effects , Signal Transduction/physiology , Sleep Deprivation/metabolism , Sleep Deprivation/physiopathology , Xanthines/pharmacology
2.
Behav Brain Res ; 331: 20-24, 2017 07 28.
Article in English | MEDLINE | ID: mdl-28506620

ABSTRACT

Sleep deprivation impairs performance in emotional memory tasks, however this effect on memory is not completely understood. Possible mechanisms may involve an alteration in neurotransmission systems, as shown by the fact that many drugs that modulate neural pathways can prevent memory impairment by sleep loss. Gastrin releasing peptide (GRP) is a neuropeptide that emerged as a regulatory molecule of emotional memory through the modulation of other neurotransmission systems. Thus, the present study addressed the effect of intraperitoneal (IP) administration of bombesin (BB) (2.5, 5.0 and 10.0µg/kg), a GRP agonist, on the performance of Wistar rats in a multiple trail inhibitory avoidance (MTIA) task, after sleep deprivation, using the modified multiple platforms method (MMPM). Sleep deprived animals exhibited acquisition and retention impairment that was not prevented by BB injection. In addition, non-sleep deprived animals treated with BB before and after the training session, but not before the test, have shown a retention deficit. In summary, BB did not improve the memory impairment by sleep loss and, under normal conditions, produced a memory consolidation deficit.


Subject(s)
Bombesin/pharmacology , Memory Disorders/chemically induced , Memory/drug effects , Sleep Deprivation , Animals , Avoidance Learning/drug effects , Disease Models, Animal , Male , Peptide Fragments/pharmacology , Rats, Wistar , Sleep Deprivation/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...